Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anna Opoku‐Agyeman"'
Autor:
Fiorella Cavalli, Melissa Davis, Olayemi O. Adeoye, Salma Khan, Jonathan V. Wooten, Rachel Schiff, Leah K. Rowland, Anna Opoku‐Agyeman, Eileen Brantley, Brittany D. Jenkins, Andrea I. Loaiza-Pérez, Gayathri Nagaraj, Petreena Campbell, Nicole Mavingire, Ubaldo Soto, Ashley Guevara, Laura Denham
Publikováno v:
Journal of Cellular Physiology. 234:108-121
More than 40% of patients with luminal breast cancer treated with endocrine therapy agent tamoxifen demonstrate resistance. Emerging evidence suggests tumor initiating cells (TICs) and aberrant activation of Src and Akt signaling drive tamoxifen resi
Autor:
Leah K. Rowland, Yonghong Zhang, Charles Wang, Gayathri Nagaraj, Nichole Mavingire, Sean (Xin) Chen, Petreena Campbell, Ubaldo Soto, Eileen Brantley, Anna Opoku-Agyeman
Publikováno v:
Cancer Research. 77:4177-4177
Despite the efficacy of anti-estrogen agent Tamoxifen, commonly used to treat patients with estrogen receptor positive (ER+) tumors, up to 40% of patients experience recurrence. Breast tumor-initiating cells (TICs), or breast cancer stem cells, exhib